Drug intelligence / Profile preview

Yi-Tong Cheng-Zhang

Development stage
Unknown
Lead developer
Shanghai Children's Medical Center
Modality
Small Molecules
Administration
Oral
01

Overview

Yi-Tong Cheng-Zhang is a Traditional Chinese Medicine (TCM) oral liquid preparation developed by the Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine. It is specifically indicated for the treatment of elevated blood lead levels (lead poisoning) in pediatric patients. The formulation is designed to facilitate the excretion of lead from the body and reduce its absorption, likely through the action of herbal constituents such as *Poria cocos* and *Fructus Crataegi* (Hawthorn), which are traditionally used to promote detoxification and metabolic health. Additionally, such preparations often incorporate essential minerals like zinc and calcium to competitively inhibit lead uptake in the gastrointestinal tract. It is primarily utilized as a hospital-specific preparation (医院制剂) in China for mild to moderate lead exposure cases.

Other names
Yitong Chengzhang益童成长Yitong Chengzhang Oral Liquid

Beyond the preview

Go deeper on Yi-Tong Cheng-Zhang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yi-Tong Cheng-Zhang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call